We validated FHIR PIT in the context of our driving use case for research and development of ICEES: impact of airborne pollutant exposures on asthma. The validation data set consisted of ~160,000 patients with “asthma-like” conditions from UNC Health Care System and the environmental data sources depicted in Figure 1, focusing initially on data from calendar year 2010 [19-21]. FHIR PIT was used to integrate the clinical and environmental data and then de-identify the data and bin feature variables before openly exposing the integrated data using ICEES. ICEES was queried using the following input parameters:
Feature variables: {
"feature_a": {
"AvgDailyPM2.5Exposure": {
"operator": "<",
"value": 3
}
},
"feature_b": {
"TotalEDInpatientVisits": {
"operator": "<",
"value": 2
}
}
}
Version of data: 1.0.0
Table: patient
Year: 2010
Cohort ID: COHORT:60
Cohort ID: COHORT:72
ICEES returned the following JSON output, which is also displayed in graphical form in Figure 2.
{
"version": "1.0.0",
"return value": {
"total": 6379,
"feature_matrix": [
[
{
"frequency": 297,
"total_percentage": 0.046559021790249254,
"row_percentage": 0.058545239503252515,
"column_percentage": 0.911042944785276
},
{
"frequency": 4776,
"total_percentage": 0.7487066938391598,
"row_percentage": 0.9414547604967475,
"column_percentage": 0.7890302329423426
}
],
[
{
"frequency": 29,
"total_percentage": 0.004546167110832419,
"row_percentage": 0.0222052067381317,
"column_percentage": 0.08895705521472393
},
{
"frequency": 1277,
"total_percentage": 0.20018811725975857,
"row_percentage": 0.9777947932618682,
"column_percentage": 0.21096976705765735
}
]
],
"feature_b": {
"feature_name": "TotalEDInpatientVisits",
"feature_qualifiers": [
{
"operator": "<",
"value": 2
},
{
"operator": ">=",
"value": 2
}
]
},
"feature_a": {
"feature_name": "AvgDailyPM2.5Exposure",
"feature_qualifiers": [
{
"operator": "<",
"value": 3
},
{
"operator": ">=",
"value": 3
}
]
},
"p_value": 1.0475066725063578e-7,
"columns": [
{
"frequency": 326,
"percentage": 0.05110518890108168
},
{
"frequency": 6053,
"percentage": 0.9488948110989184
}
],
"rows": [
{
"frequency": 5073,
"percentage": 0.795265715629409
},
{
"frequency": 1306,
"percentage": 0.204734284370591
}
],
"chi_squared": 28.284141190385228
}
{
"version": "1.0.0",
"return value": {
"total": 13176,
"feature_matrix": [
[
{
"frequency": 976,
"total_percentage": 0.07407407407407407,
"row_percentage": 0.08721293896881423,
"column_percentage": 0.9216241737488197
},
{
"frequency": 10215,
"total_percentage": 0.7752732240437158,
"row_percentage": 0.9127870610311858,
"column_percentage": 0.8430304530824462
}
],
[
{
"frequency": 83,
"total_percentage": 0.00629933211900425,
"row_percentage": 0.04181360201511335,
"column_percentage": 0.07837582625118036
},
{
"frequency": 1902,
"total_percentage": 0.14435336976320584,
"row_percentage": 0.9581863979848867,
"column_percentage": 0.15696954691755385
}
]
],
"feature_b": {
"feature_name": "TotalEDInpatientVisits",
"feature_qualifiers": [
{
"operator": "<",
"value": 2
},
{
"operator": ">=",
"value": 2
}
]
},
"feature_a": {
"feature_name": "AvgDailyPM2.5Exposure",
"feature_qualifiers": [
{
"operator": "<",
"value": 3
},
{
"operator": ">=",
"value": 3
}
]
},
"p_value": 7.050580654566281e-12,
"columns": [
{
"frequency": 1059,
"percentage": 0.08037340619307833
},
{
"frequency": 12117,
"percentage": 0.9196265938069217
}
],
"rows": [
{
"frequency": 11191,
"percentage": 0.84934729811779
},
{
"frequency": 1985,
"percentage": 0.15065270188221008
}
],
"chi_squared": 47.01332258473862
}
These results indicate that the proportion of patients with two or more annual emergency department or inpatient visits for respiratory issues was higher among patients exposed to relatively high average daily levels of particulate matter < 2.5-microns in diameter (PM2.5) than among those exposed to relatively low average daily levels of PM2.5. Moreover, asthma exacerbations, as defined by two or more annual emergency department or inpatient visits for respiratory issues, were more common among African Americans than among Caucasians.
We then examined prednisone use in relation to asthma exacerbations among African Americans and Caucasians. The ICEES query is shown below.
Feature variables: {
"feature_a": {
"TotalEDInpatientVisits": {
"operator": "<",
"value": 2
}
},
"feature_b": {
"Prednisone": {
"operator": "=",
"value": 0
}
}
}
Version of data: 1.0.0
Table: patient
Year: 2010
Cohort ID: COHORT:60
Cohort ID: COHORT:72
ICEES returned the following results, which are shown in tabular form in Table 3.
{
"version": "1.0.0",
"return value": {
"total": 6379,
"feature_matrix": [
[
{
"frequency": 4536,
"total_percentage": 0.7110832418874432,
"row_percentage": 0.8079800498753117,
"column_percentage": 0.8941454760496748
},
{
"frequency": 1078,
"total_percentage": 0.16899200501646025,
"row_percentage": 0.19201995012468828,
"column_percentage": 0.8254211332312404
}
],
[
{
"frequency": 537,
"total_percentage": 0.08418247374196583,
"row_percentage": 0.7019607843137254,
"column_percentage": 0.10585452395032525
},
{
"frequency": 228,
"total_percentage": 0.03574227935413074,
"row_percentage": 0.2980392156862745,
"column_percentage": 0.17457886676875958
}
]
],
"feature_b": {
"feature_name": "Prednisone",
"feature_qualifiers": [
{
"operator": "=",
"value": 0
},
{
"operator": "<>",
"value": 0
}
]
},
"feature_a": {
"feature_name": "TotalEDInpatientVisits",
"feature_qualifiers": [
{
"operator": "<",
"value": 2
},
{
"operator": ">=",
"value": 2
}
]
},
"p_value": 9.26500631308178e-12,
"columns": [
{
"frequency": 5073,
"percentage": 0.795265715629409
},
{
"frequency": 1306,
"percentage": 0.204734284370591
}
],
"rows": [
{
"frequency": 5614,
"percentage": 0.8800752469039035
},
{
"frequency": 765,
"percentage": 0.11992475309609657
}
],
"chi_squared": 46.47805966021564
}
{
"version": "1.0.0",
"return value": {
"total": 13176,
"feature_matrix": [
[
{
"frequency": 10071,
"total_percentage": 0.764344262295082,
"row_percentage": 0.8573982632385493,
"column_percentage": 0.8999195782325082
},
{
"frequency": 1675,
"total_percentage": 0.1271250758955677,
"row_percentage": 0.14260173676145071,
"column_percentage": 0.8438287153652393
}
],
[
{
"frequency": 1120,
"total_percentage": 0.08500303582270795,
"row_percentage": 0.7832167832167832,
"column_percentage": 0.10008042176749174
},
{
"frequency": 310,
"total_percentage": 0.02352762598664238,
"row_percentage": 0.21678321678321677,
"column_percentage": 0.1561712846347607
}
]
],
"feature_b": {
"feature_name": "Prednisone",
"feature_qualifiers": [
{
"operator": "=",
"value": 0
},
{
"operator": "<>",
"value": 0
}
]
},
"feature_a": {
"feature_name": "TotalEDInpatientVisits",
"feature_qualifiers": [
{
"operator": "<",
"value": 2
},
{
"operator": ">=",
"value": 2
}
]
},
"p_value": 1.3181707519332912e-13,
"columns": [
{
"frequency": 11191,
"percentage": 0.84934729811779
},
{
"frequency": 1985,
"percentage": 0.15065270188221008
}
],
"rows": [
{
"frequency": 11746,
"percentage": 0.8914693381906497
},
{
"frequency": 1430,
"percentage": 0.10853066180935034
}
],
"chi_squared": 54.82406086877697
}
Table 3. Relationship between prednisone use and asthma exacerbations, defined as two or more annual ED or inpatient visits for respiratory issues, among African Americans and Caucasians.
|
Patients with < 2 annual ED/inpatient visits for respiratory issues
N (%)
|
Patients with ≥ 2 annual ED/inpatient visits for respiratory issues
N (%)
|
Chi square, P value
|
African Americans (N = 6,379)
|
Prednisone
No
Yes
|
4536 (89.41%)
537 (10.59%)
|
1078 (82.54%)
228 (17.46%)
|
X2 = 46.4781,
P < 0.0001
|
Caucasians (N = 13,176)
|
Prednisone
No
Yes
|
10071 (89.99%)
1120 (10.01%)
|
1675 (84.38%)
310 (15.62%)
|
X2 = 54.8241,
P < 0.0001
|
Abbreviations: ED = emergency department.
These results indicate that prednisone use was more common among patients with asthma exacerbations than among those without asthma exacerbations, as expected given that prednisone is generally reserved for patients with severe disease [22]. While this finding was true for both African Americans and Caucasian, the effect was more pronounced among African Americans than among Caucasians.
In sum, we successfully applied FHIR PIT to integrate clinical and environmental data and then openly expose the data for interrogation via ICEES, thereby replicating and extending published literature demonstrating the impact of exposure to airborne particulate matter on asthma (e.g., 4) and racial disparities in asthma exacerbations [23].